发明申请
US20070197498A1 NOVEL DIPHENYLAZETIDINONE WITH IMPROVED PHYSIOLOGICAL PROPERTIES, PROCESS FOR ITS PREPARATION, MEDICAMENTS COMPRISING THIS COMPOUND, AND ITS USE
失效
具有改善的生理特性的新型二氢噻吩酮，其制备方法，包含该化合物的药物及其用途
- 专利标题： NOVEL DIPHENYLAZETIDINONE WITH IMPROVED PHYSIOLOGICAL PROPERTIES, PROCESS FOR ITS PREPARATION, MEDICAMENTS COMPRISING THIS COMPOUND, AND ITS USE
- 专利标题（中）： 具有改善的生理特性的新型二氢噻吩酮，其制备方法，包含该化合物的药物及其用途
-
申请号： US11690993申请日： 2007-03-26
-
公开(公告)号： US20070197498A1公开(公告)日： 2007-08-23
- 发明人: Gerhard JAEHNE , Wendelin Frick , Andreas Lindenschmidt , Stefanie Flohr , Hubert Heuer , Hans-Ludwig Schaefer , Werner Kramer , Eric Galia , Heiner Glombik
- 申请人： Gerhard JAEHNE , Wendelin Frick , Andreas Lindenschmidt , Stefanie Flohr , Hubert Heuer , Hans-Ludwig Schaefer , Werner Kramer , Eric Galia , Heiner Glombik
- 申请人地址： DE Frankfurt
- 专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人地址： DE Frankfurt
- 优先权： DE10314610.5 20030401
- 主分类号： A61K31/397
- IPC分类号： A61K31/397 ; C07D205/02
摘要：
Novel diphenylazetidinone, process for its preparation, medicaments comprising this compound and their use The invention relates to the compound of the formula 1 and to its physiologically acceptable salts. The compound is suitable, for example, as a hypolipidemic.
公开/授权文献
信息查询
